Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep;58(5):340-5.
doi: 10.5468/ogs.2015.58.5.340. Epub 2015 Sep 22.

Performance of Momguard, a new non-invasive prenatal testing protocol developed in Korea

Mi-Young Lee  1 , Dae-Yeon Cho  2 , Hye-Sung Won  1 , Ah Reum Hwang  1 , Bada Jeong  1 , Jihun Kim  2 , Mijin Oh  2
Affiliations

Performance of Momguard, a new non-invasive prenatal testing protocol developed in Korea

Mi-Young Lee et al. Obstet Gynecol Sci. 2015 Sep.

Abstract

Objective: To evaluate the performance of Momguard, non-invasive prenatal test (NIPT) for detecting trisomy (T) 21, T18, T13, and sex-chromosome abnormalities recently developed in Korea.

Methods: This preliminary study formed part of a large prospective cohort study conducted at Asan Medical Center, Seoul, Korea. Only pregnant women who underwent both NIPT and confirmatory karyotyping were included in this study. NIPT results were compared with those of karyotype analyses.

Results: Among 93 eligible cases, NIPT results could not be obtained in one case due to a low fetal cell-free DNA fraction. Based on NIPT, eight cases of fetal aneuploidies, including T21 (n=5), T18 (n=2), and T13 (n=1), were identified. For T21 and T18, the sensitivity and specificity of NIPT were both 100%, with a false-positive and false-negative rate of 0% and a positive-predictive value of 100%. One patient classified as having intermediate risk for T13 by NIPT was confirmed to have T13 by karyotyping, and there were no false-negative cases. No cases of sex-chromosome anomalies were detected by NIPT or karyotyping during the study period.

Conclusion: Momguard is a reliable screening tool for detecting T21 and T18. For T13 and sex-chromosome anomalies, further prospective studies are necessary to confirm its utility.

Keywords: Aneuploidy; Down syndrome; Patau syndrome; Prenatal diagnosis; Trisomy 18.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1. Correlation between cell-free DNA (cfDNA) fraction and gestational age in 46 pregnancies with male fetuses (R2=0.1636, P<0.01). Unlike for male fetuses, for which Y chromosomes are effective markers, it is particularly difficult to quantitate the fetal fraction in female fetuses; there are no universal and reliable fetal markers available to estimate the fetal fraction in maternal plasma [15]. Therefore, cfDNA level was analyzed using only male fetuses.
Fig. 2
Fig. 2. Interactive dot diagram for fetal aneuploidy. The Z-scores of chromosomes 21, 18 and 13 are represented on the Y-axis. The solid line represents the high risk cutoff value, and the dotted line represents the intermediate risk cutoff value for each aneuploidy test. T, trisomy.
See this image and copyright information in PMC

References

    1. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol. 2007;110:1459–1467. - PubMed
    1. Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther. 2010;27:1–7. - PubMed
    1. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med. 2005;353:2001–2011. - PubMed
    1. Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol. 2004;191:45–67. - PubMed
    1. Rozenberg P, Bussieres L, Chevret S, Bernard JP, Malagrida L, Cuckle H, et al. Screening for Down syndrome using first-trimester combined screening followed by second-trimester ultrasound examination in an unselected population. Am J Obstet Gynecol. 2006;195:1379–1387. - PubMed